BNC210: an investigational α7-nicotinic acetylcholine receptor modulator for the treatment of anxiety disorders

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 2013. DOI:10.1176/appi.books.9780890425596.
   Google Scholar
• Battaglia S, Orsolini S, Borgomaneri S, et al. Characterizing cardiac autonomic dynamics of fear learning in humans. Psychophysiology. 2022;59:e14122.
   PubMedGoogle Scholar
• Battaglia S, Thayer JF. Functional interplay between central and autonomic nervous systems in human fear conditioning. Trends Neurosci. 2022;45:504–506.
   PubMedGoogle Scholar
• Bystritsky A, Khalsa SS, Cameron ME, et al. Current diagnosis and treatment of anxiety disorders. P T Peer-Rev J Formul Manag. 2013;38:30–57
   Google Scholar
• Spielberger CD, Gorsuch R, Lushene R, et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, USA: Consulting Psychologists Press, Inc; 1983.
   Google Scholar
• Carter RM, Wittchen H-U, Pfister H, et al. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 2001;13:78–88.
   PubMed Web of Science ®Google Scholar
• Deakin JFW. Depression and 5HT. Int Clin Psychopharmacol. 1991;6:23–32.
   PubMedGoogle Scholar
• McTeague LM, Rosenberg BM, Lopez BS, et al. Identification of common neural circuit disruptions in emotional processing across psychiatric disorders. Am J Psychiatry. 2020;177:411–421.
   PubMed Web of Science ®Google Scholar
• Chen C. Recent advances in the study of the comorbidity of depressive and anxiety disorders. Adv Clin Exp Med. 2022;31:355–358
   PubMedGoogle Scholar
• Michaelis BB. Epidemiology of anxiety disorders in the 21st century. Dialog Clin Neurosci. 2015;17:327–335.
   PubMedGoogle Scholar
• Barlow DH. Anxiety and its disorders. New York City, USA: Guilford Press; 2004.
   Google Scholar
• Wilmer MT, Anderson K, Reynolds M. Correlates of quality of life in anxiety disorders: review of recent research. Curr Psychiatry Rep. 2021;23:1–9.
   Google Scholar
• World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Geneva, Switzlerland: World Health Organization; 1993.
   Google Scholar
• Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialog Clin Neurosci. 2017;19:159–168.
   PubMed Web of Science ®Google Scholar
• Aktar E, Nikolić M, Bögels SM. Environmental transmission of generalized anxiety disorder from parents to children: worries, experiential avoidance, and intolerance of uncertainty. Dialog Clin Neurosci. 2017;19:137–147.
   PubMed Web of Science ®Google Scholar
• Kessler RC. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• de Lijster JM, Dierckx B, Utens EMWJ, et al. The age of onset of anxiety disorders. Can J Psychiatry. 2016;62:237–246.
   PubMedGoogle Scholar
• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593.
   PubMed Web of Science ®Google Scholar
• Moreno AL, Osório FDL, Martín-santos R, et al. Heritability of social anxiety disorder: a systematic review of methodological designs. Arch Clin Psychiatry Sao Paulo. 2016;43:83–92
   Google Scholar
• Boehme S, Ritter V, Tefikow S, et al. Brain activation during anticipatory anxiety in social anxiety disorder. Soc Cogn Affect Neurosci. 2013;9:1413–1418.
   PubMedGoogle Scholar
• Wise T, Patrick F, Meyer N, et al. Cholinergic modulation of disorder-relevant neural circuits in generalized anxiety disorder. Biol Psychiatry. 2020;87:908–915.
   PubMedGoogle Scholar
• Perkins A, Patrick F, Wise T, et al. Cholinergic modulation of disorder-relevant human defensive behaviour in generalised anxiety disorder. Transl Psychiatry. 2021;11:13.
   PubMedGoogle Scholar
• Etkin A, Prater KE, Hoeft F, et al. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry. 2010;167:545–554.
   PubMed Web of Science ®Google Scholar
• Nitschke J, Sarinopoulos I, Oathes DJ, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry. 2009;166:302–310.
   PubMed Web of Science ®Google Scholar
• Etkin A, Egner T, Peraza DM, et al. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron. 2006;52:1121.
   Google Scholar
• Robinson OJ, Charney DR, Overstreet C, et al. The adaptive threat bias in anxiety: amygdala dorsomedial prefrontal cortex coupling and aversive amplification. NeuroImage. 2012;60:523–529.
   PubMedGoogle Scholar
• Strawn JR, Geracioti L, Rajdev N, et al. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018;19:1057–1070.
   PubMed Web of Science ®Google Scholar
• Edinoff AN, Nix CA, Hollier J, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021;13:594–607.
   PubMedGoogle Scholar
• Hidalgo RB, Tupler LA, Davidson JRT. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol (Oxf). 2007;21:864–872
   PubMed Web of Science ®Google Scholar
• Pollack MH, van Ameringen M, Simon NM, et al. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014;171:44–53.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Recommendations | generalised anxiety disorder and panic disorder in adults: management | guidance | NICE. London, UK: Nice.org.uk; 2011.
   Google Scholar
• Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – version 3. Part I: anxiety disorders. World J Biol Psychiatry. 2022;1–39. DOI:10.1080/15622975.2022.2086295.
   Google Scholar
• Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – version 3. Part II: OCD and PTSD. World J Biol Psychiatry. 2022;1–17. DOI:10.1080/15622975.2022.2086296.
   Google Scholar
• Ballenger JC. Translational implications of the amygdala-stria terminalis model for the clinical anxiety disorders. Biol Psychiatry. 1998;44:1204–1207.
   PubMedGoogle Scholar
• Roy-Byrne P. Treatment-refractory anxiety; definition, risk factors, and treatment challenges. Dialog Clin Neurosci. 2015;17:191–206.
   PubMed Web of Science ®Google Scholar
• Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007;47:699–729.
   PubMed Web of Science ®Google Scholar
• Purves, Dale. Neuroscience. 5th eds. Sunderland, USA: Sinauer; 2008.
   Google Scholar
• Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363–396.
   PubMed Web of Science ®Google Scholar
• Yakel FD, Dendritic JL. Ca 2+ signalling due to activation of α7-containing nicotinic acetylcholine receptors in rat hippocampal neurons: ca 2+ signalling of dendritic nAChRs in rat hippocampal neurons. J Physiol. 2007;582:597–611.
   PubMedGoogle Scholar
• Noviello CM, Gharpure A, Mukhatsimova N, et al. Structure and gating mechanism of the α7 nicotinic acetylcholine receptor. Cell. 2021;184:2121–2134.e13.
   PubMed Web of Science ®Google Scholar
• Klein RC, Yakel JL. Functional somato-dendritic a7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. J Physiol. 2006;576:865–872.
   PubMedGoogle Scholar
• Mineur YS, Fote GM, Blakeman S, et al. Multiple nicotinic acetylcholine receptor subtypes in the mouse amygdala regulate affective behaviors and response to social stress. Neuropsychopharmacology. 2015;41:1579–1587.
   PubMedGoogle Scholar
• Arias HR, Targowska-Duda KM, García-Colunga J, et al. Is the antidepressant activity of selective serotonin reuptake inhibitors mediated by nicotinic acetylcholine receptors? Molecules. 2021;26:2149.
   PubMedGoogle Scholar
• Hambrecht-Wiedbusch VS, Mitchell MF, Firn KA, et al. Benzodiazepine site agonists differentially alter acetylcholine release in rat amygdala. Anesth Analg. 2014;118:1293–1300.
   PubMed Web of Science ®Google Scholar
• O’Connor S, Andrianbeloson E, Huyard B, et al. P.4.d.001 BNC210 is a novel, fast acting compound with potent anxiolytic activity and no side effects. Eur Neuropsychopharmacol. 2008;18:S495.
   Google Scholar
• Kremmidiotis G, Doolin E, Metzger D, et al. P.4.a.005 Pharmacodynamic effects of single oral doses of the novel anxiolytic compound BNC210 in healthy male volunteers. Eur Neuropsychopharmacol. 2011;21:S528.
   Google Scholar
• O’Connor SM, Grishin AA, Poiraud E, et al. The novel anxiolytic compound BNC210 is a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor. Neuroscience 2014 Conference, Washington DC, USA, 2014.
   Google Scholar
• De Gregorio D, Inserra A, Enns JP, et al. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. Neuropsychopharmacology. 2022;47:1188–1198.
   PubMedGoogle Scholar